Your browser doesn't support javascript.
loading
Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
Dobos, G; de Masson, A; Ram-Wolff, C; Beylot-Barry, M; Pham-Ledard, A; Ortonne, N; Ingen-Housz-Oro, S; Battistella, M; d'Incan, M; Rouanet, J; Franck, F; Vignon-Pennamen, M D; Franck, N; Carlotti, A; Boulinguez, S; Lamant, L; Petrella, T; Dalac, S; Joly, P; Courville, P; Rivet, J; Dereure, O; Amatore, F; Taix, S; Grange, F; Durlach, A; Quéreux, G; Josselin, N; Moulonguet, I; Mortier, L; Dubois, R; Maubec, E; Laroche, L; Michel, L; Templier, I; Barete, S; Nardin, C; Augereau, O; Vergier, B; Bagot, M.
Affiliation
  • Dobos G; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
  • de Masson A; INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.
  • Ram-Wolff C; Université de Paris, Paris, France.
  • Beylot-Barry M; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
  • Pham-Ledard A; INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.
  • Ortonne N; Université de Paris, Paris, France.
  • Ingen-Housz-Oro S; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
  • Battistella M; INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.
  • d'Incan M; Université de Paris, Paris, France.
  • Rouanet J; Dermatology Department, Université de Bordeaux, Bordeaux, France.
  • Franck F; Dermatology Department, Université de Bordeaux, Bordeaux, France.
  • Vignon-Pennamen MD; Pathology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France.
  • Franck N; Dermatology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France.
  • Carlotti A; INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.
  • Boulinguez S; Université de Paris, Paris, France.
  • Lamant L; Pathology Department, Saint-Louis Hospital, AP-HP, Paris, France.
  • Petrella T; Dermatology and Cutaneous Oncology, Estaing University Hospital, Université de Clermont-Ferrand, Clermont-Ferrand, France.
  • Dalac S; Pathology Department, NHE Clermont et SIPATH UNILABS, Clermont-Ferrand, France.
  • Joly P; Pathology Department, NHE Clermont et SIPATH UNILABS, Clermont-Ferrand, France.
  • Courville P; Pathology Department, Saint-Louis Hospital, AP-HP, Paris, France.
  • Rivet J; Dermatology Department, Cochin Hospital, AP-HP, Paris, France.
  • Dereure O; Pathology Department, Cochin Hospital, AP-HP, Paris, France.
  • Amatore F; Dermatology Department, Cahors Hospital, Toulouse, France.
  • Taix S; Pathology and Cytopathology Department, Institut Universitaire du Cancer Toulouse, Toulouse, France.
  • Grange F; Pathology Department, Dijon Bourgogne University Hospital, Dijon, France.
  • Durlach A; Dermatology Department, Dijon Bourgogne University Hospital, Dijon, France.
  • Quéreux G; Dermatology Department, Rouen University Hospital, INSERM U1234, Rouen Institute for Research and Innovation in Biomedicine, Rouen, France.
  • Josselin N; Pathology Department, Rouen University Hospital, INSERM U1234, Rouen Institute for Research and Innovation in Biomedicine, Rouen, France.
  • Moulonguet I; Dermatology Department, Université de Bordeaux, Bordeaux, France.
  • Mortier L; Pathology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France.
  • Dubois R; Dermatology Department, Montpellier University Hospital, Montpellier, France.
  • Maubec E; Department of Dermatology and Oncodermatology, Aix-Marseille University, AP-HM, Timone Hospital, Marseille, France.
  • Laroche L; Department of Pathology, Aix-Marseille University, AP-HM, Timone Hospital, Marseille, France.
  • Michel L; Dermatology Department, Robert Debré University Hospital, Reims, France.
  • Templier I; Pathology Department, Reims University Hospital, Reims, France.
  • Barete S; Dermatology Department, Nantes University Hospital, Nantes, France.
  • Nardin C; Pathology Department, Nantes University Hospital, Nantes, France.
  • Augereau O; Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
  • Vergier B; Dermatology Department, Claude Huriez University Hospital, INSERM U1189, Université de Lille, Lille, France.
  • Bagot M; Pathology Department, Claude Huriez University Hospital, Lille, France.
Br J Dermatol ; 184(6): 1059-1067, 2021 06.
Article de En | MEDLINE | ID: mdl-33131055
ABSTRACT

BACKGROUND:

Primary cutaneous lymphomas (PCLs) are a heterogeneous group of T-cell (CTCL) and B-cell (CBCL) malignancies. Little is known about their epidemiology at initial presentation in Europe and about potential changes over time.

OBJECTIVES:

The aim of this retrospective study was to analyse the frequency of PCLs in the French Cutaneous Lymphoma Registry (GFELC) and to describe the demography of patients.

METHODS:

Patients with a centrally validated diagnosis of primary PCL, diagnosed between 2005 and 2019, were included.

RESULTS:

The calculated incidence was unprecedently high at 1·06 per 100 000 person-years. The number of included patients increased yearly. Most PCL subtypes were more frequent in male patients, diagnosed at a median age of 60 years. The relative frequency of rare CTCL remained stable, the proportion of classical mycosis fungoides (MF) decreased, and the frequency of its variants (e.g. folliculotropic MF) increased. Similar patterns were observed for CBCL; for example, the proportion of marginal-zone CBCL increased over time.

CONCLUSIONS:

Changes in PCL frequencies may be explained by the emergence of new diagnostic criteria and better description of the entities in the most recent PCL classification. Moreover, we propose that an algorithm should be developed to confirm the diagnosis of PCL by central validation of the cases.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Lymphome B / Lymphome T cutané / Mycosis fongoïde Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Br J Dermatol Année: 2021 Type de document: Article Pays d'affiliation: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Lymphome B / Lymphome T cutané / Mycosis fongoïde Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Br J Dermatol Année: 2021 Type de document: Article Pays d'affiliation: France